JP2017522284A5 - - Google Patents

Download PDF

Info

Publication number
JP2017522284A5
JP2017522284A5 JP2016572799A JP2016572799A JP2017522284A5 JP 2017522284 A5 JP2017522284 A5 JP 2017522284A5 JP 2016572799 A JP2016572799 A JP 2016572799A JP 2016572799 A JP2016572799 A JP 2016572799A JP 2017522284 A5 JP2017522284 A5 JP 2017522284A5
Authority
JP
Japan
Prior art keywords
methyl
cyclohexyl
potassium
carbonate
hydroxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016572799A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017522284A (ja
JP6594351B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/035558 external-priority patent/WO2015195478A1/en
Publication of JP2017522284A publication Critical patent/JP2017522284A/ja
Publication of JP2017522284A5 publication Critical patent/JP2017522284A5/ja
Application granted granted Critical
Publication of JP6594351B2 publication Critical patent/JP6594351B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016572799A 2014-06-16 2015-06-12 新規中間体を含むアルキル化アリールピペラジン及びアルキル化アリールピペリジン化合物の製造方法 Active JP6594351B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462012701P 2014-06-16 2014-06-16
US62/012,701 2014-06-16
PCT/US2015/035558 WO2015195478A1 (en) 2014-06-16 2015-06-12 Processes for making alkylated arylpiperazine and alkylated arylpiperidine compounds including novel intermediates

Publications (3)

Publication Number Publication Date
JP2017522284A JP2017522284A (ja) 2017-08-10
JP2017522284A5 true JP2017522284A5 (enExample) 2019-03-14
JP6594351B2 JP6594351B2 (ja) 2019-10-23

Family

ID=54835598

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016572799A Active JP6594351B2 (ja) 2014-06-16 2015-06-12 新規中間体を含むアルキル化アリールピペラジン及びアルキル化アリールピペリジン化合物の製造方法

Country Status (10)

Country Link
US (3) US9790237B2 (enExample)
EP (1) EP3154967B1 (enExample)
JP (1) JP6594351B2 (enExample)
CA (1) CA2951917C (enExample)
ES (1) ES2826603T3 (enExample)
HR (1) HRP20201638T1 (enExample)
HU (1) HUE052277T2 (enExample)
PL (1) PL3154967T3 (enExample)
SI (1) SI3154967T1 (enExample)
WO (1) WO2015195478A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL233778B1 (pl) 2016-07-19 2019-11-29 Adamed Spolka Z Ograniczona Odpowiedzialnoscia Sposob wytwarzania brekspiprazolu oraz zastosowanie zwiazkow posrednich w sposobie wytwarzania brekspiprazolu
EP3870292A4 (en) 2018-10-26 2022-11-09 The Research Foundation for The State University of New York COMBINATION OF SEROTONIN-SPECIFIC RESUPPUT INHIBITOR AND SEROTONIN 1A RECEPTOR PARTIAL AGONIST TO REDUCE L-DOPA-INDUCED DYSKINESIA
CN116848108A (zh) * 2021-03-31 2023-10-03 四川科伦药物研究院有限公司 一种鲁拉西酮可注射混悬液及其制备方法
CN115073444A (zh) * 2022-08-05 2022-09-20 山东科源制药股份有限公司 一种盐酸鲁拉西酮环氧杂质的精制去除方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE967826C (de) 1954-06-14 1957-12-19 Henkel & Cie Gmbh Verfahren zur Herstellung von Aryloxyalkanol-schwefelsaeurehalbestersalzen
GB1511159A (en) * 1975-07-10 1978-05-17 Leo A Amines preparation
WO1990006303A1 (en) 1988-12-02 1990-06-14 Pfizer Inc. Arylpiperidine derivatives
JP2800953B2 (ja) 1990-07-06 1998-09-21 住友製薬株式会社 新規なイミド誘導体
US5159100A (en) 1990-12-19 1992-10-27 Lonza Ltd. Process for the production of cyclopropanenitrile derivatives
US6467121B1 (en) 2000-08-15 2002-10-22 Goodway Technologies Corporation Rotary tube scrubber
UA79300C2 (en) 2002-08-12 2007-06-11 Janssen Pharmaceutica Nv N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion
EP1535616B1 (en) 2002-08-22 2009-05-13 Dainippon Sumitomo Pharma Co., Ltd. Remedy for integration dysfunction syndrome
USRE45573E1 (en) 2003-07-29 2015-06-23 Sumitomo Dainippon Pharma Co., Ltd. Process for producing imide compound
US20060257987A1 (en) * 2003-08-20 2006-11-16 Gonzalez Valcarcel Isabel Cris Ppar modulators
US7276610B2 (en) 2003-08-27 2007-10-02 Janssen Pharaceutica, Nv Aryl piperidine amides
WO2005080976A1 (ja) 2004-02-20 2005-09-01 Dainippon Sumitomo Pharma Co., Ltd. 統合失調症の記憶・学習機能障害治療薬のin vivoスクリーニング方法
CN101198331B (zh) 2005-06-13 2012-05-02 大日本住友制药株式会社 增溶化制剂
RU2009104750A (ru) 2006-08-17 2010-09-27 Ф. Хоффманн-Ля Рош Аг (Ch) Производные арилпиперазина и их применение
US20090076027A1 (en) 2007-09-17 2009-03-19 Protia, Llc Deuterium-enriched lurasidone
CN101868228B (zh) 2007-11-21 2016-12-07 大日本住友制药株式会社 口腔内崩解片
US8735397B2 (en) 2010-03-29 2014-05-27 Vanderbilt University Method for treating schizophrenia and related diseases
WO2011136384A1 (en) 2010-04-26 2011-11-03 Dainippon Sumitomo Pharma Co., Ltd. A process of a quaternary ammonium salt using phosphate
EP2563790B1 (en) 2010-04-26 2016-09-14 Sumitomo Dainippon Pharma Co., Ltd. A process of a quaternary ammonium salt
US8258139B2 (en) 2010-11-08 2012-09-04 Dainippon Sumitomo Pharma Co., Ltd. Method of treatment for mental disorders
WO2012063246A1 (en) 2010-11-11 2012-05-18 Mapi Pharma Ltd. Amorphous form of lurasidone hydrochloride
WO2012107890A2 (en) 2011-02-10 2012-08-16 Ranbaxy Laboratories Limited Crystalline forms of lurasidone hydrochloride
WO2012123858A1 (en) 2011-03-14 2012-09-20 Ranbaxy Laboratories Limited Amorphous lurasidone hydrochloride
WO2012131606A1 (en) 2011-04-01 2012-10-04 Ranbaxy Laboratories Limited Process for the preparation of an antipsychotic agent
EP2707000A4 (en) 2011-05-13 2014-11-26 Dainippon Sumitomo Pharma Co TREATMENT AND CONTROL OF CNS DISORDERS
US8981095B2 (en) 2011-07-28 2015-03-17 Mapi Pharma Ltd. Intermediate compounds and process for the preparation of lurasidone and salts thereof
WO2013030722A1 (en) 2011-08-26 2013-03-07 Ranbaxy Laboratories Limited Crystalline lurasidone hydrochloride

Similar Documents

Publication Publication Date Title
JP2017522284A5 (enExample)
JP2022133462A5 (enExample)
JP2019207442A5 (enExample)
JP2017122107A5 (enExample)
MX2013009603A (es) Suspension mejorada de tablero de pared de yeso y metodo para elaborar de la misma.
ES2485825T3 (es) Intermedio de rosuvastatina cálcica y método de preparación del mismo
AR116300A1 (es) Proceso para la preparación de 6-(2,4-diclorofenil)-5-[4-[(3s)-1-(3-fluoropropil)pirrolidin-3-il]oxifenil]-8,9-dihidro-7h-benzo[7]anuleno-2-carboxilato de metilo
Rawat et al. Chemoselective one-pot synthesis of β-keto sulfones from ketones
JP2015524407A5 (enExample)
JP2015524406A5 (enExample)
JP2009527517A5 (enExample)
WO2012160280A3 (fr) Procede de preparation de bis(fluorosulfonyl)imidure de lithium ou sodium
JP2017522357A5 (enExample)
JP2017501197A5 (enExample)
JP2018528182A5 (enExample)
RU2013107770A (ru) Способ получения дронедарона
JP2009242405A5 (enExample)
AR099989A1 (es) Proceso de preparación de (s)-1-(1-(4-cloro-3-fluorofenil)-2-hidroxietil)-4-(2-((1-metil-1h-pirazol-5-il)amino)pirimidin-4-il)-2(1h)-ona y sus sales
JP2018522018A5 (enExample)
JP2016188255A5 (enExample)
JP2009524615A5 (enExample)
MA39205A1 (fr) Polymères contenant des amines primaires utiles en tant qu'inhibiteurs de tartre
EA201071424A1 (ru) Сульфонатные соли 2-амино-3-карбэтоксиамино-6-(4-фторбензиламино)пиридина
MX2010001864A (es) Metodo para la preparacion de acido montelukast en un medio liquido ionico.
JP2008247919A5 (enExample)